Navigation Links
E.U. Panel Backs Novartis' Mock-up Pandemic Flu Vaccine

Europe's main medical regulator said it has adopted a positive opinion recommending the granting of a marketing authorization for Focetria, from Novartis //AG (NVS) Vaccines and Diagnostics unit.

Focetria is a mock-up pandemic influenza vaccine, intended for the prevention of influenza during an officially declared pandemic situation, once the pandemic viral strain has been included. It is the second mock-up pandemic influenza vaccine to receive a positive opinion from the Committee.

Mock-up pandemic influenza vaccines are approved only for use in a declared pandemic influenza situation. The objective is to have a marketing authorization in place that can be changed quickly in the event of a pandemic to include the virus strain responsible, once it has been identified.

Source-Bio-Bio Technology
'"/>




Page: 1

Related medicine news :

1. Panel suggests selling allergy drugs OTC
2. Anti-Quota Stir: Resident Docs Demand Experts Panel
3. Circumcision Studies to Continue Says Health Panel
4. Panel to Help Combat HIV/AIDS In Asia-Pacific Region
5. Breast Cancer Review Panel Adds Two Experts
6. Shingles Vaccine For Older People - Panel Recommendation
7. Complaints Against US Federal lab Over-ruled by Panel
8. Generic Biologics – U.S Panel Hearing Draws Mixed Response
9. Expert Panel Sets Limits on Pesticide Residues in Soft Drinks
10. Mercks Pain Reliever Arcoxia Rejected by US Federal Advisory Panel
11. National Pharmaceutical Policy Referred to Ministerial Panel
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Panel Backs Novartis Mock Pandemic Flu Vaccine

(Date:5/23/2013)... May 23, 2013 Fresh Healthy Vending ... machines stocked with healthy food and drinks in locations ... company’s in-house, full-service marketing and advertising department has a ... the media for their franchisees, and to promote the ... been featured in many leading publications and TV networks ...
(Date:5/23/2013)... Lake City, Utah (PRWEB) May 23, 2013 ... Chevreau, PhD, R.D., published an article today on Tatalou.com ... an illness-free vacation. , The article, titled “ How ... why it’s important to carry hand sanitizer, when it’s ... to watch out for seafood, the importance of staying ...
(Date:5/23/2013)... Washington, DC (PRWEB) May 23, 2013 Teen ... through 2011, according to new data released today ... that time, the teen birth rate dropped at least 15% ... states. , There were also dramatic declines among all ... ,     Birth rates declined 40% or more for ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... (BI) solutions, announced today that Paul ... Insight, will speak at the 2013 International Medical ... titled, “Unlock Expense & Revenue Visibility from Your ... Wednesday, May 29 from 2:30-3:25 p.m. in Azalea ...
(Date:5/23/2013)... May 23, 2013 Jim Fitzpatrick just ... Fitzpatrick Advertising developed yet another outside-of-the-box approach to reaching ... News.com, he brings daily newscasts to the retail automotive ... delivery of a broadcast news format. , CBTNews.com ... automotive news. Co-anchors Bridget Everett and Russell Brown host ...
Breaking Medicine News(10 mins):Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2Health News:How to Stay Healthy While Traveling 2Health News:Dimensional Insight to Demonstrate How Hospitals Can Use Business Intelligence within MEDITECH Environments at 2013 International MUSE Conference 2Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2
... by Dr Roger Bayston in the School of Clinical Sciences, ... an allied health professional training fellowship of almost 160,000 from ... bacterial infections associated with broken bones. Pins used ... to 40 per cent of patients being treated in this ...
... NY) The American Association for Cancer Research (AACR), ... awarded Susan Band Horwitz, Ph.D. , the Rose ... molecular pharmacology at Albert Einstein College of Medicine ... Achievement in Cancer Research. Dr. Horwitz, who is ...
... 2011 Those light-emitting diodes marketed as safe, environmentally ... and a dozen other potentially hazardous substances, according to ... next generation of lighting. But as we try to ... or contribute to global warming, we have to be ...
... 10 (HealthDay News) -- People are more likely to recall an ... it is over than if they expect it to occur again, ... as equally enjoyable whether they think they,ll do them again or ... discomfort if they have a bad experience and allow them to ...
... at St. Michael,s Hospital and the Institute for Clinical and ... that will help doctors predict the probability of death in ... in the journal Circulation , found that the tool ... and one year after an ischemic stroke. An ischemic stroke, ...
... living in deprived neighbourhoods are twice as likely to have ... Coast, according to a new study by researchers at St. ... of illness and death are significantly higher in poorer neighbourhoords. ... a big role in how strongly they are affected," said ...
Cached Medicine News:Health News:Anti-bacterial collar to help mend broken bones 2Health News:Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research 2Health News:Susan Band Horwitz, Ph.D., of Einstein, receives lifetime achievement award in cancer research 3Health News:LED products billed as eco-friendly contain toxic metals, study finds 2Health News:New online tool predicts probability of death from stroke 2Health News:Coastal Canadians living in high-risk neighborhoods in poorer health: Study 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, ... announced today that it will present new results ... an industry conference sponsored by the PML Consortium ... Idec).  JC polyomavirus (JCV) is the causative agent ... tyrosine kinase inhibitor in an extended release formulation, ...
(Date:5/23/2013)... 2013 InspireMD, Inc. ("InspireMD" ... in embolic protection stents, today announced new 6-month ... Elevation Reperfusion) trial demonstrating that the MGuard Embolic ... eluting stents in all-cause mortality in ST segment ... trial were presented at the InspireMD STEMI Symposium ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
... Jan. 4, 2012  OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) ... custirsen (OGX-011/TV-1011) in patients with advanced non-small cell ... online version of the January 2012 issue of ... data provide additional clinical evidence for the potential ...
... announced today the closing of a $30 million Series B ... fund development of Elevation,s new aerosol therapy for patients living ... in the round, including Canaan Partners , TPG ... Venture Partners . In conjunction with this financing, Elevation has ...
Cached Medicine Technology:OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology 2OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology 3OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology 4Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 2Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 3
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses....
5 inch (12.7 cm), 2 x 5 mm blade....
Nicati foreign body spud....
In reversible handle for removing foreign bodies....
Medicine Products: